Bradley M. Minrovic

New Class of Adjuvants Enables Lower Dosing of Colistin Against <i>Acinetobacter baumannii</i>

Bradley M. Minrovic, David Jung, Roberta J. Melander et al. · ACS Infectious Diseases · 2018 · 34 citations · Full text

Antibiotic Adjuvant, Colistin Activity, Antibiotic Resistance +17

Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against <i>Pseudomonas aeruginosa</i>

Veronica B. Hubble, Brittany A. Hubbard, Bradley M. Minrovic et al. · ACS Infectious Diseases · 2018 · 30 citations · Full text

Antibiotic Adjuvant, Antimicrobial Chemotherapy, Bacterial Pathogens +19

Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions between 2-Aminoimidazoles and the Response Regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp.

Morgan E. Milton, Bradley M. Minrovic, Danni L. Harris et al. · Frontiers in Molecular Biosciences · 2018 · 26 citations · Full text

Small Molecule Potentiation of Gram-Positive Selective Antibiotics against <i>Acinetobacter baumannii</i>

Sara E. Martin, Roberta J. Melander, Christopher M. Brackett et al. · ACS Infectious Diseases · 2019 · 26 citations · Full text

The Discovery of 2‐Aminobenzimidazoles That Sensitize <i>Mycobacterium smegmatis</i> and <i>M. tuberculosis</i> to β‐Lactam Antibiotics in a Pattern Distinct from β‐Lactamase Inhibitors

T. Vu Nguyen, Meghan S. Blackledge, Erick A. Lindsey et al. · Angewandte Chemie International Edition · 2017 · 25 citations